x
Summer Flowers In This Section
 
A Phase 3, Multi-Site, Open-Label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Principal Investigator (?)
Study Number
F11052
Summary
The main objective of this study is to evaluate the long-term safety of CP-690,550 in patients being treated for moderate to severe chronic plaque psoriasis. This is an open label extension study available to patients who participated in one of the qualifying studies with CP-690,550 providing entry criteria is met. 
Phase (?)
Phase III
Sponsor (?)
Contact

Debra Rodgers
(603) 650-3160

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0